• PDF / 167,127 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 73 Downloads / 181 Views

DOWNLOAD

REPORT

1173-5503/20/0860-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 22 Aug 2020 No. 860

1

Recommend Documents

Bevacizumab + capecitabine not cost effective in mCRC

162 48 111KB

Pharmacist care cost effective for CVD prevention in diabetes

177 42 111KB

Guideline-based stepped care not cost effective for depression

171 104 184KB

Patient-initiated DMARD self-monitoring service not cost effective

190 97 167KB

Vaccinating boys along with girls against HPV not cost effective

141 15 139KB

Targeted immune modulators not cost effective in ulcerative colitis

146 89 163KB

Ivacaftor not cost effective in cystic fibrosis with G551D mutation

163 21 182KB

Cognitive behavioural therapy at various delivery modes cost effective

155 40 163KB

Cost-Effective

168 109 57MB

70-gene signature cost effective in guiding breast cancer therapy

114 17 184KB

Antibiotics as an Adjunct to Source Control: Revised Surgical Infection Society Guidelines for Antimicrobial Therapy of

150 53 47MB

Animal-Assisted Interventions as an Adjunct to Therapy for Youth: Clinician Perspectives

239 83 669KB